Receptors, Progesterone
"Receptors, Progesterone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives.
Descriptor ID |
D011980
|
MeSH Number(s) |
D12.776.826.750.765
|
Concept/Terms |
Receptors, Progesterone- Receptors, Progesterone
- Progesterone Receptor
- Receptor, Progesterone
- Progestin Receptors
- Receptors, Progestin
- Progesterone Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Progesterone".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Progesterone".
This graph shows the total number of publications written about "Receptors, Progesterone" by people in this website by year, and whether "Receptors, Progesterone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1991 | 1 | 2 | 3 | 1992 | 2 | 2 | 4 | 1993 | 3 | 1 | 4 | 1994 | 3 | 2 | 5 | 1995 | 2 | 1 | 3 | 1996 | 2 | 0 | 2 | 1997 | 4 | 0 | 4 | 1998 | 4 | 2 | 6 | 1999 | 1 | 1 | 2 | 2000 | 3 | 1 | 4 | 2001 | 4 | 0 | 4 | 2002 | 2 | 3 | 5 | 2003 | 6 | 2 | 8 | 2004 | 3 | 0 | 3 | 2005 | 5 | 3 | 8 | 2006 | 6 | 3 | 9 | 2007 | 5 | 4 | 9 | 2008 | 4 | 1 | 5 | 2009 | 4 | 1 | 5 | 2010 | 2 | 6 | 8 | 2011 | 6 | 5 | 11 | 2012 | 9 | 8 | 17 | 2013 | 3 | 7 | 10 | 2014 | 3 | 3 | 6 | 2015 | 2 | 5 | 7 | 2016 | 3 | 3 | 6 | 2017 | 3 | 4 | 7 | 2018 | 3 | 3 | 6 | 2019 | 3 | 0 | 3 | 2020 | 1 | 4 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Progesterone" by people in Profiles.
-
Comasco E, Kopp Kallner H, Bixo M, Hirschberg AL, Nyback S, de Grauw H, Epperson CN, Sundström-Poromaa I. Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial. Am J Psychiatry. 2021 03 01; 178(3):256-265.
-
Brechbuhl HM, Vinod-Paul K, Gillen AE, Kopin EG, Gibney K, Elias AD, Hayashi M, Sartorius CA, Kabos P. Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells. Mol Carcinog. 2020 10; 59(10):1129-1139.
-
McGee EE, Kim CH, Wang M, Spiegelman D, Stover DG, Heng YJ, Collins LC, Baker GM, Farvid MS, Schedin P, Jindal S, Tamimi RM, Eliassen AH. Erythrocyte membrane fatty acids and breast cancer risk by tumor tissue expression of immuno-inflammatory markers and fatty acid synthase: a nested case-control study. Breast Cancer Res. 2020 07 22; 22(1):78.
-
Finlay-Schultz J, Jacobsen BM, Riley D, Paul KV, Turner S, Ferreira-Gonzalez A, Harrell JC, Kabos P, Sartorius CA. New generation breast cancer cell lines developed from patient-derived xenografts. Breast Cancer Res. 2020 06 23; 22(1):68.
-
Kar A, Koto K, Walker D, Trudeau T, Edgerton S, Thor A, Gutierrez-Hartmann A. ETS transcription factor ESE-1/Elf3 is an independent prognostic factor of survival in HR+HER2+ breast cancer patients. Breast Cancer Res Treat. 2020 Aug; 182(3):601-612.
-
Peluso JJ, Pru CA, Liu X, Kelp NC, Pru JK. Progesterone receptor membrane component 1 and 2 regulate granulosa cell mitosis and survival through a NF?B-dependent mechanism†. Biol Reprod. 2019 06 01; 100(6):1571-1580.
-
Fettig LM, Sartorius CA. Phospho-PR Isoforms and Cancer Stem Cells: What Does the FOXO1 Say? Endocrinology. 2019 05 01; 160(5):1067-1068.
-
Sangaramoorthy M, Hines LM, Torres-Mejía G, Phipps AI, Baumgartner KB, Wu AH, Koo J, Ingles SA, Slattery ML, John EM. A Pooled Analysis of Breastfeeding and Breast Cancer Risk by Hormone Receptor Status in Parous Hispanic Women. Epidemiology. 2019 05; 30(3):449-457.
-
Giulianelli S, Riggio M, Guillardoy T, Pérez Piñero C, Gorostiaga MA, Sequeira G, Pataccini G, Abascal MF, Toledo MF, Jacobsen BM, Guerreiro AC, Barros A, Novaro V, Monteiro FL, Amado F, Gass H, Abba M, Helguero LA, Lanari C. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERa and PRB?4 isoform to MYC regulatory sequences. Int J Cancer. 2019 10 01; 145(7):1874-1888.
-
Szwarc MM, Hai L, Gibbons WE, White LD, Mo Q, Kommagani R, Lanz RB, DeMayo FJ, O'Malley BW, Lydon JP. Retinoid signaling controlled by SRC-2 in decidualization revealed by transcriptomics Reproduction. 2018 10 16; 156(5):387-395.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|